2014
DOI: 10.24926/iip.v5i3.347
|View full text |Cite
|
Sign up to set email alerts
|

Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8)

Abstract: Erratum Redacted by authors in order to address a question regarding the use of a measure.    Type: Original Research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
119
1
13

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 139 publications
(135 citation statements)
references
References 36 publications
2
119
1
13
Order By: Relevance
“…10 Out of 35 patients, 24 (68.5%) were males and 11 (31%) were females. Rise in mean pre-transfusion haemoglobin in good and partial responders (p<0.001) was significant but not that of poor responders (p-0.092).…”
Section: Resultsmentioning
confidence: 99%
“…10 Out of 35 patients, 24 (68.5%) were males and 11 (31%) were females. Rise in mean pre-transfusion haemoglobin in good and partial responders (p<0.001) was significant but not that of poor responders (p-0.092).…”
Section: Resultsmentioning
confidence: 99%
“…The first two items refer to the unintentional non-adherence to treatment due to forgetfulness and carelessness. The last two items concern the intentional cessation of medication when feeling better or worse [37][38] In 2008 the modified eight-item scale (MMAS-8) was developed to overcome the limitations of MMAS-4 [36]. The first seven items are dichotomous response categories with yes or no, and the last item inquires how often the responder misses the daily doses of medications, with five response options and corresponding different scoring.…”
Section: Morisky Medication Adherence Scales (Mmas-4 and Mmas-8)mentioning
confidence: 99%
“…The Morisky Medication Adherence Scale (MMAS) is a short and easy survey identifying barriers to treatment adherence. So far, this is the most extensively studied scale, validated for a large number of diseases [35][36][37][38][39][40][41][42][43][44][45][46][47][48][49]. The Self-efficacy for Appropriate Medication Use (SEAMS) [50][51], the Hill-Bone Compliance Scale [52][53][54][55], the Brief Medication Questionnaire (BMQ) [56][57][58][59], the Treatment Adherence Questionnaire for Patients with Hypertension (TAQPH) [66], the Martin-Bayarre-Grau questionnaire (MBG) [67][68], and the Adherence Self-Report Questionnaire (ASRQ) [69] focus on patients with chronic cardiovascular diseases, mainly with hypertension.…”
Section: Expert Opinionmentioning
confidence: 99%
“…Adherence Self-Report Questionnaire) oraz skala MARS (ang. The Medication Adherence Rating Scale) [10].…”
Section: Metody Oceny Przestrzegania Zaleceń Terapeutycznychunclassified